The Biological Computing Company (TBC), founded by neurosurgeons Alex Ksendzovsky and Jon Pomeraniec, has partnered with Amazon Web Services to integrate its biological AI optimization tools into the cloud platform. The startup uses living rat and human stem-cell-derived neurons grown on multi-electrode arrays to process visual data and improve transformer-based AI models.
The company’s technology functions as software plugins, allowing users to leverage biological signals without direct interaction with the hardware. Each array contains up to 4,096 electrodes that record neural responses to encoded data. These responses are converted into adapters that enhance the performance of existing generative video systems.
In a July 30 proof-of-concept using Decart’s OASIS 500M model, the company reported a 2x improvement in video quality, a 4.4x reduction in inference costs, and a 3x increase in video coherence. TBC plans to launch commercial applications for computer vision and generative video by the end of 2026, including a text-to-video model.
TBC emerged from stealth in February 2026, announcing a $25 million seed round led by Primary Ventures and the opening of a wet lab in San Francisco’s Mission Bay. The firm has since conducted public demonstrations for AWS clients and hosted a live stream on Twitch on September 30 to showcase real-time processing of neuron-encoded data.
